Pipo Saude
PrivateLast Round
Series A
Extension
Aug 14, 2024
Total Funding Raised
$30.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pipo Saude operates in Healthcare & Life Sciences and is based in São Paulo. Its latest recorded funding round was a Series A Extension round in August 2024.
Pipo Saude is a healthtech company that provides a digital platform for companies to purchase and manage employee health benefits.
Sector
Healthcare & Life Sciences
Verticals
InsurTech, HR, Healthcare Analytics
Business Model
B2B
Customer Profile
Marketplace Commission, Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pipo Saude Comparables
Compare Pipo Saude with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sanus | 79% | |
| Piwi | 77% | |
| Acrisure | 77% |
For institutional investors. Book with your work email.
Pipo Saude Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Aug 14, 2024 | ||||
| Series A | Jul 28, 2021 | ||||
| Seed | Jun 16, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pipo Saude Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Monashees | Series A, Series A Extension, Seed |
| Thrive Capital | Series A Extension, Series A |
| ONEVC | Series A, Seed |
| Endeavor Scale Up Ventures | Series A Extension |
| FJ Labs | Series A Extension |
| Atlantico | Series A |
| Kaszek | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2026
Added Riaspace, an IT services startup, as a customer.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresAug 12, 2026
On Aug 12th '26, Pipo Saude appoints co-founder Thiago Torres as VP of Growth, where he leads growth initiatives, commercial expansion, and new-business development.
- promotesAug 12, 2026
Pipo Saude promotes former COO Lorena Coimbra to VP of Clients, where she leads the areas responsible for integrated client experience, on Aug 12th '26.
- hiresAug 12, 2026
Pipo Saude appoints Lorena as VP of Clients to strengthen relationships across its client portfolio and service experience after she leads operations for five years.
For institutional investors. Book with your work email.
Pipo Saude Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pipo Saude's valuation, stock price, and market status.
Is Pipo Saude a public or private company?
Pipo Saude is a private company.
What is the current stock price of Pipo Saude?
Pipo Saude is a private company, so its shares have no public market price. Caplight tracks Pipo Saude's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pipo Saude worth (valuation)?
Valuation information for Pipo Saude is not publicly available.
Can I buy Pipo Saude stock?
Pipo Saude shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pipo Saude's last funding round?
Pipo Saude's most recent funding round was Series A Extension on August 14, 2024.
Who are the main investors in Pipo Saude?
Key investors in Pipo Saude include Monashees, Thrive Capital.
Will Pipo Saude IPO soon?
No public IPO plans have been announced for Pipo Saude.
How can I track Pipo Saude secondary market activity?
Caplight tracks bids, offers, and trades in Pipo Saude's shares on secondary markets.